Guardian:口腔性行为与喉癌有关?

2013-06-08 Guardian 生物360

Michael Douglas: "because, without wanting to get too specific, this particular cancer is caused by HPV, which actually comes about from cunnilingus." 多年来,人们认为吸烟和饮酒是导致喉癌的主要危险因素。但是,周一,英国报纸《卫报》(Th

Michael Douglas: "because, without wanting to get too specific, this particular cancer is caused by HPV, which actually comes about from cunnilingus."

多年来,人们认为吸烟和饮酒是导致喉癌的主要危险因素。但是,周一,英国报纸《卫报》(The Guardian)报道,演员迈克尔·道格拉斯(Michael Douglas)认为自己的喉癌是因为口交时受到感染而引起的,这突显出了一个让很多科学家感到震惊的趋势。

68岁的道格拉斯之前曾推测,多年的吸烟和饮酒和他的疾病有关。他的发言人后来表示,虽然道格拉斯提到口交与癌症有关,但他并没有说自己的喉癌是由此引起的。然而,《卫报》援引道格拉斯的话说,“我不想多谈细节,这种癌症是由人乳头瘤病毒(human papillomavirus,缩写HPV)引起的,而它实际上源自为女性口交。”

的确,近年来,科学家发现由一种HPV病毒株所引发的喉癌数量急剧增加,而这种病毒株可以通过口交传播。这种被称作HPV16型的病毒也是导致很多女性得宫颈癌的原因。

20世纪80年代,只有少数喉癌病例与HPV感染有关。过去,得这种病的患者都是70多岁的老人,而且他们都大量吸烟或酗酒。

如今,所有喉癌病例中大约有70%都是由HPV引起的,而30年前,这个数据大概是15%。现在的病人往往是已经身为人夫或人父的中年男子,经济条件较好,不吸烟也不酗酒。男性被确诊罹患HPV相关喉癌的几率要比女性高三倍。

HPV的菌株有很多种,而且这种病毒十分常见,多数性活跃的成人早晚都会接触到它。多数人都能抵抗它的感染,不出现任何症状。但是,在极少数人身上,慢性感染会在舌根附近以及口腔后面的区域引发口咽癌。

医生说,由HPV引起的喉癌比抽烟所引起的喉癌更容易治疗。虽然这些癌症的发生率正在增加,但它仍然较少见,10万人中大概有3人会得这种病。研究尚未证明针对HPV的疫苗能够预防喉癌,但很多医生都对此坚信不疑。

癌症的出现通常是在首次感染HPV的几十年后,而且这种疾病的诊断也可能会针对患者的伴侣提出一些敏感的问题,他们会去考虑,自己的伴侣是如何感染的,而且还担心自己也会感染这种病毒。

“这是一种通过性来传播的病毒,所以这种疾病本身显然就会让我的病人与伴侣之间的讨论很尴尬,”罗伯特·I·哈达德(Robert I. Haddad)博士说。他在波士顿丹娜-法伯癌症研究所(Dana-Farber Cancer Institute)的头部和颈部肿瘤学项目担任疾病中心负责人。

2009年,62岁的托尼·西莫特斯(Tony Simotes)得知在他的喉咙内有一个肿瘤,被诊断为口咽喉癌三期。西莫特斯既不抽烟也不喝酒。他和妻子露西(Lucy)在得知癌症与HPV有关时首先感到轻松了些,因为这提高了他可能被治愈的几率。

“但随后我的心开始忐忑不安,心想这是否对我也意味着什么呢?”50岁的露西说,“因为这种癌症来自于一种病毒,我说不定也携带了它。”

她说自己进行了一次巴氏试验,结果呈阴性。

马萨诸塞州莱诺克斯的莎士比亚剧团(Shakespeare & Company)艺术总监和总裁西莫特斯说,因为夫妻双方之前都曾结过婚,所以他们并不忌讳谈论癌症及其原因。“我们知道在我们见面之前都曾经历过丰富的生活,”他说,“现实情况就是有很多人携带病毒但没有受其影响。”

西莫特斯接受了化疗和放疗,他的癌症现在处于缓解期。

上周末,在美国临床肿瘤学会(American Society of Clinical Oncology)的一次会议上展示的一项研究中,哈达德博士和其他研究者首次证明,患有HPV导致的喉癌者的性伴侣,其口腔感染HPV的几率并不比一般人高。这项研究对200多人进行了约1年的跟踪检查。

哈达德博士称,研究结果表明,配偶和长期性伴侣无需采取特殊的防护措施或改变其性行为。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=163817, encodeId=439b16381eb8, content=接种HPV疫苗呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58556641119D92082.jpg, createdBy=f7e21996619, createdName=1e1b9a80m26(暂无匿称), createdTime=Sun Dec 18 15:42:08 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38377, encodeId=b518383e77e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38376, encodeId=90c7383e65e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:53:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636691, encodeId=26581636691ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 09:34:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322342, encodeId=454d1322342ca, content=<a href='/topic/show?id=cde152e227a' target=_blank style='color:#2F92EE;'>#性行为#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52722, encryptionId=cde152e227a, topicName=性行为)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360778, encodeId=32571360e7806, content=<a href='/topic/show?id=795a4012140' target=_blank style='color:#2F92EE;'>#喉癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40121, encryptionId=795a4012140, topicName=喉癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=)]
    2016-12-18 1e1b9a80m26(暂无匿称)

    接种HPV疫苗呀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=163817, encodeId=439b16381eb8, content=接种HPV疫苗呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58556641119D92082.jpg, createdBy=f7e21996619, createdName=1e1b9a80m26(暂无匿称), createdTime=Sun Dec 18 15:42:08 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38377, encodeId=b518383e77e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38376, encodeId=90c7383e65e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:53:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636691, encodeId=26581636691ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 09:34:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322342, encodeId=454d1322342ca, content=<a href='/topic/show?id=cde152e227a' target=_blank style='color:#2F92EE;'>#性行为#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52722, encryptionId=cde152e227a, topicName=性行为)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360778, encodeId=32571360e7806, content=<a href='/topic/show?id=795a4012140' target=_blank style='color:#2F92EE;'>#喉癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40121, encryptionId=795a4012140, topicName=喉癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=)]
    2015-10-11 hlycom3356

    感谢作者分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=163817, encodeId=439b16381eb8, content=接种HPV疫苗呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58556641119D92082.jpg, createdBy=f7e21996619, createdName=1e1b9a80m26(暂无匿称), createdTime=Sun Dec 18 15:42:08 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38377, encodeId=b518383e77e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38376, encodeId=90c7383e65e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:53:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636691, encodeId=26581636691ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 09:34:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322342, encodeId=454d1322342ca, content=<a href='/topic/show?id=cde152e227a' target=_blank style='color:#2F92EE;'>#性行为#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52722, encryptionId=cde152e227a, topicName=性行为)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360778, encodeId=32571360e7806, content=<a href='/topic/show?id=795a4012140' target=_blank style='color:#2F92EE;'>#喉癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40121, encryptionId=795a4012140, topicName=喉癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=)]
    2015-10-11 hlycom3356

    感谢作者分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=163817, encodeId=439b16381eb8, content=接种HPV疫苗呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58556641119D92082.jpg, createdBy=f7e21996619, createdName=1e1b9a80m26(暂无匿称), createdTime=Sun Dec 18 15:42:08 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38377, encodeId=b518383e77e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38376, encodeId=90c7383e65e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:53:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636691, encodeId=26581636691ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 09:34:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322342, encodeId=454d1322342ca, content=<a href='/topic/show?id=cde152e227a' target=_blank style='color:#2F92EE;'>#性行为#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52722, encryptionId=cde152e227a, topicName=性行为)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360778, encodeId=32571360e7806, content=<a href='/topic/show?id=795a4012140' target=_blank style='color:#2F92EE;'>#喉癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40121, encryptionId=795a4012140, topicName=喉癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=163817, encodeId=439b16381eb8, content=接种HPV疫苗呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58556641119D92082.jpg, createdBy=f7e21996619, createdName=1e1b9a80m26(暂无匿称), createdTime=Sun Dec 18 15:42:08 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38377, encodeId=b518383e77e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38376, encodeId=90c7383e65e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:53:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636691, encodeId=26581636691ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 09:34:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322342, encodeId=454d1322342ca, content=<a href='/topic/show?id=cde152e227a' target=_blank style='color:#2F92EE;'>#性行为#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52722, encryptionId=cde152e227a, topicName=性行为)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360778, encodeId=32571360e7806, content=<a href='/topic/show?id=795a4012140' target=_blank style='color:#2F92EE;'>#喉癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40121, encryptionId=795a4012140, topicName=喉癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=)]
    2013-06-10 xugc
  6. [GetPortalCommentsPageByObjectIdResponse(id=163817, encodeId=439b16381eb8, content=接种HPV疫苗呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58556641119D92082.jpg, createdBy=f7e21996619, createdName=1e1b9a80m26(暂无匿称), createdTime=Sun Dec 18 15:42:08 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38377, encodeId=b518383e77e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38376, encodeId=90c7383e65e, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:53:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636691, encodeId=26581636691ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 09:34:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322342, encodeId=454d1322342ca, content=<a href='/topic/show?id=cde152e227a' target=_blank style='color:#2F92EE;'>#性行为#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52722, encryptionId=cde152e227a, topicName=性行为)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360778, encodeId=32571360e7806, content=<a href='/topic/show?id=795a4012140' target=_blank style='color:#2F92EE;'>#喉癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40121, encryptionId=795a4012140, topicName=喉癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Mon Jun 10 00:34:00 CST 2013, time=2013-06-10, status=1, ipAttribution=)]

相关资讯

ASCO 2013:HPV阳性口咽癌患者的配偶口腔HPV感染不会增加(HOTSPOT研究)

     在2013年美国临床肿瘤学会(ASCO)年会上,公布的 HOTSPOT研究结果显示,与普通人群相比,配偶口腔HPV感染的阳性检出率不会增加,相处多年夫妇不需要因为诊断为口咽癌而改变亲昵和性行为。    很多人乳头瘤病毒(human papilloma virus, HPV)阳性口咽癌(oropharyngeal cancer,O

SMFM:高危HPV感染的孕妇先兆子痫风险翻倍

  旧金山——在母胎医学会(SMFM)年度妊娠研讨会上,德克萨斯大学加尔维斯顿医学分部的Mollie McDonnold博士报告称,一项回顾性队列研究表明,如果女性在孕早期感染高危型人乳头状瘤病毒(HPV),那么其发生先兆子痫的几率至少翻倍。 Mollie McDonnold博士   在这项研究中,如果发现女性存在意义不明的非典型鳞状上皮细胞(ASCUS)且DNA检测发现高危亚型,或者存在

JAMA:HPV疫苗减量免疫方案或具非劣效性

人类乳头状瘤病毒(HPV)疫苗的接种次数及其成本已经成为其在全球范围内予以广泛推广的障碍,女孩只接种2剂HPV疫苗免疫方案或许成为可能。为了鉴别那些接受2次HPV疫苗免疫的女孩HPV-16和HPV-18平均抗体水平与那些接受3次疫苗免疫的女性相比是否具有非劣效性,温哥华英属哥伦比亚大学的Dobson博士及其同事开展了一项研究。他们发现,对于间隔6个月给予2次HPV疫苗免疫的女孩来说,最后一次接种1

JID:HIV患者直肠HPV高感染率和持久性导致癌症的高发

HIV感染者患HPV(人乳头状瘤病毒)相关癌症的风险较高,而且发病率与解剖位置有关,如HIV感染者直肠癌的发病率是普通人群的25倍,而口咽癌的发病率是普通人群的2-6倍。免疫缺陷人群中,宫颈癌风险的升高与宫颈HPV感染高发病率和高持久性相关。为了在HIV患者中探究HPV感染发病率和持久性的差异与不同直肠-口腔HPV患病率和癌症发生率的关系,来自美国巴尔的摩的Daniel C. Beachler和同

HPV亚型检测有助于宫颈癌筛查

 美国新版指南推荐“联合检测”,高危基因亚型提示疾病预期 宫颈癌是世界第三大女性恶性肿瘤,是中国女性第二大最常见的恶性肿瘤。据世界卫生组织估计,全世界每年有逾47万新发宫颈癌病例,中国每年新发宫颈癌病例数 约占世界总发病数的28%。据权威机构估计,若缺乏适当、有效的筛查方法及预防计划,至2025年,亚洲的宫颈癌发病率将上升40%。 近年来,宫颈癌病因人类乳头状瘤病毒(HPV)的发现

科学家研发DNA产品识别高危宫颈癌

  据美国《星岛日报》报道,全美女性死亡人数最多的疾病是宫颈癌,人类乳突病毒(HPV)是致病主要元凶。但是,感染HPV病毒并不意味着未来必罹患癌症,全美75%的女性和五成男性在一生中会感染HPV,两位女性华裔生命科学家温可仪、郑淑玲共同创办的公司,以HPV DNA技术明确地界定病例是否为临时感染或致癌隐患,大大降低社会医疗成本。   温可仪表示,宫颈癌是全美女性最大的杀手,也是全球妇女